Cannformatics
Cannformatics45
Cannformatics
Biotechnology company personalizing medical cannabis treatment using metabolic biomarker analysis.
About
What does Cannformatics do?
Cannformatics is a biotechnology startup focused on personalizing medical cannabis treatment by identifying and applying saliva-based Cannabis-Responsive™ biomarkers. Their proprietary technology analyzes metabolic biomarkers to quantify individual responses to cannabis, guiding the optimization of products, dosage, and consumption methods. Initially focusing on Autism Spectrum Disorder (ASD), they plan to expand to other conditions like anxiety, pain, and neurodegenerative diseases.
What is Cannformatics's revenue?
StartupHub estimates Cannformatics's annual revenue at $725K (range $472K to $1.1M, 66% confidence), based on comparable companies in the sector.
Where is Cannformatics headquartered?
Cannformatics is headquartered in San Francisco, United States.
When was Cannformatics founded?
Cannformatics was founded in 2017.
What industry does Cannformatics operate in?
Cannformatics operates in Healthcare, Cannabis, Bioinformatics, Personal, Biomarkers, Autism.
How many employees does Cannformatics have?
Cannformatics has approximately 4 people on record.
“Revolutionizing Autism Therapy: Cannformatics Leverages Machine Learning to Target Metabolic Imbalances.”
View on Reddit“Cannformatics, an early-stage biotechnology company, has recently published a paper that could be a game-changer in the world of Autism Spectrum Disorder (ASD) treatment. The research focuses on using Cannabis-Responsive Biomarkers & Machin…”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.